TECHNOLOGY

Advanced Biologics was initially formed in 2009 when it introduced the innovative OsteoAMP® product line to the orthopaedic and neurosurgery markets.  OsteoAMP was divested in 2014 to Bioventus

 

Subsequent technology introductions include a cellular bone matrix, OsseoGEN™, and an allograft derived growth factor, ProteiOS®.  Both currently being distributed by Biologica Technologies.

OsseoGEN is Advanced Biologics' cell based allograft matrix distributed by Biologica Technologies.  For additional information, click on this link.

ProteiOS is Advanced Biologics' allograft derived growth factor distributed by Biologica Technologies.  For additional information, click on this link.

Tel:    800.272.0267

Mon - Fri: 9am - 5pm PST

© 2021 Advanced Biologics